Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
Not yet recruiting · NCT07131449 · Registry updated 2025-08-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Not stated | 2025-08-20 | NCT07131449 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Xinxiang Medical College | 34 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||